BOSTON, May 11, 2011—Experts from Harvard Clinical Research Institute (HCRI), a leading international provider of clinical trial services, will be in attendance at EuroPCR and will tweet commentary and insights from the event, which will be held in Paris May 17-20.
We look forward to participating at EuroPCR, and to sharing the insights of our clinicians with the international cardiology community,” said Mordecai Kramer, Executive Director, Business Development, HCRI (mordecai.kramer@hcri.harvard.edu)
About Harvard Clinical Research Institute (HCRI)
HCRI (www.hcri.harvard.edu) is a not-for-profit organization that advances the research of pharmaceuticals, biologics, and medical devices by developing collaborations between industry and academia. HCRI’s partners include leading medical centers with worldwide recognition for high-quality medical care and state-of-the-art facilities, including Harvard Medical School, Beth Israel Deaconess Medical Center and Partners HealthCare.
